Scientia Agricultura Sinica ›› 2016, Vol. 49 ›› Issue (15): 3054-3062.doi: 10.3864/j.issn.0578-1752.2016.15.019

• RESEARCH NOTES • Previous Articles    

The Detection Methods of the Related Substances in Cefquinome Sulfate Intramammary Infusion

LIU Mao-lin1, LIU Yi-ming1, XU Fei1, ZHANG Dao-kang1, HUANG Hui-li1, LI Han2, LI Xiu-bo1   

  1. 1Feed Research Institute, Chinese Academy of Agricultural Sciences/National Reference Laboratory of Drug in Feeds, Beijing 100081
    2Beijing Institute of Veterinary Drugs Control, Beijing 100107
  • Received:2016-03-01 Online:2016-08-01 Published:2016-08-01

Abstract: 【Objective】 The detection methods of the related substances in cefquinome sulfate intramammary infusion were optimized by referencing the cefquinome sulfate injection in Veterinary Drug Quality Standard Assembly. A specific, sensitive, simple and rapid method was developed, which could be used to analyze the related substance in cefquinome sulfate intramammary infusion, effectively. And it will be useful for its quality control and process optimization. 【Method】 The instrument method was made by the pharmacopoeia requirements. The separation was performed on sodium perchlorate buffer (3.45 g NaClO4·H2O was dissolved in 1 000 mL water, mixed in 12 mL phosphoric acid and 115 mL acetonitrile, and adjusted pH to 3.6 with triethylamine) as the mobile phase at flow rate of 1.0 mL·min-1. The detection wave length was 270 nm and the injection amount of sample solution was 20 µL. The LOD and concentration of the related substance in cefquinome sulfate were estimated by HPLC area normalization method. The linearity, the RSD of injection precision and method precision were tested. For the specificity test, by using 0.2 mol·L-1 HCL, 0.2 mol·L-1 NaOH to destroy the drug for 4 h, using 10% H2O2 to destroy the drug for 30 min and 90 high temperature to destroy the drug for 1 h. The before and after destroyed samples were detected by HPLC after preparation. And the main-substances’ area, related-substances’ concentration, and their resolutions were contrasted with each other, and the number of the peak values of the impurities was also contrasted. 【Result】 After a series of dilutions of the cefquinome sulfate intramammary infusion, when the concerntration of the main component was at 7.5 µg·mL-1, the S/N of the related-substance was no less than 3, and through calculation of the LOD of the related substance was 0.05 µg·mL-1, and the RSD of injection precision and method precision of 100 µg·mL-1 were 0.8% and 0.6%, respectively. The calibration curve of the related substances was a liner equation as y = 45935x-130.03 with a correlation coefficient of 1. The infusions were degraded by almost 10%, 10%, 30%, and 20% under the conditions of acid, alkali, an oxidizing agent, and high temperature, respectively. The retention time and resolution of cefquinome and related-substances were good, and the concentration and numbers of the impurities were added. After detecting the concentration of related substances of the 3 batches of cefquinome sulfate intramammary infusion, and calculated by HPLC method, it was found that the area of related substances were less than 2% of Cef, which met the the Quality Standards of Veterinary Drugs Provisions. 【Conclusion】 The method is simple and easy, selective and sensitive, which can be used to analyze the related substances in agents efficiently.

Key words: cefquinome sulfate intramammary infusion, related substance, HPLC method

[1]    高金兴. 头孢喹肟在牛奶中残留的HPLC检测及消除规律研究[D]. 扬州: 扬州大学, 2009.
GAO J X. Determination of cefquinome residues by HPLC and its residue depletion in milk[D]. Yangzhou: Yangzhou University, 2009. (in Chinese)
[2]    BOTTNER A, SCHMID P, HUMKE R. In vitro efficacy of cefquinome (INN) and other anti-infective drugs against bovine bacterial isolates from Belgium, France, Germany, the Netherlands, and the United Kingdom. ZentralbI Veterinarmed B, 1995, 42(6): 377-383.
[3]    SUHREN G, KNAPPSTEIN K. Detection of cefquinome in milk by liquid chromatography and screening methods. Analytica Chimica Acta, 2003, 483(1): 363-372.
[4]    杜向党, 李新生, 吴宁鹏, 张素梅. 头孢喹诺的最新研究进展. 中国畜牧兽医, 2006, 33(9): 15-17.
DU X D, LI X S, WU N P, ZHANG S M. The new research advance of cefquinome. China Animal Husbandry & Veterinary Medicine, 2006, 33(9): 15-17. (in Chinese)
[5]    陈道新, 张超, 潘益. 硫酸头孢喹肟的合成. 中国医药工程杂质, 2014, 45(8): 708-710.
CHEN D X, ZHANG C, PAN Y. Synthesis of cefquinome sulfate. Chinese Journal of Pharmaceuticals, 2014, 45(8): 708-710. (in Chinese)
[6]    邵意阳, 屈一新, 任慧. 硫酸头孢喹肟的合成. 中国医药工程杂志, 2007, 38(6): 405-406.
SHAO Y Y, QU Y X, REN H. Synthesis of cefquinome sulfate. Chinese Journal of Pharmaceuticals, 2007, 38(6): 405-406. (in Chinese)
[7]    李长青, 闫祥华, 薛俊娟, 马凤龙, 乔彦良. 硫酸头孢喹肟的合成. 应用化工, 2008, 37(2): 231-232.
LI C Q, YAN X H, XUE J J, MA F L, QIAO Y L. Synthesis of cefquinome sulfate. Applied Chemical Industry, 2008, 37(2): 231-232. (in Chinese)
[8]    杨美丽, 郑国钧. 硫酸头孢喹肟的合成. 化学试剂, 2008, 30(10): 787-788.
YANG M L, ZHENG G J. Synthesis of cefquinome sulfate. Chemical Reagents, 2008, 30(10): 787-788. (in Chinese)
[9]    刘美瑞, 赵地顺, 刘宝树, 刘林英, 汪学良, 李俊盼, 葛京京. 头孢喹肟研究进展. 中国畜牧兽医, 2013, 40(4): 216-220.
LIU M R, ZHAO D S, LIU B S, LIU L Y, WANG X L, LI J P, GE J J. Research advance on cefquinome. China Animal Husbandry & Veterinary Medicine, 2013, 40(4): 216-220. (in Chinese)
[10]   农业部兽药评审中心. 兽用化学药物杂质研究技术指导原则[S]. 北京: 化学工业出版社, 2012.
China Institute of Veterinary Drugs Control. Technology Guiding Principle of The Study on Veterinary Chemical Impurities[S]. Beijing: Chemical Industry Press, 2012. (in Chinese)
[11]   张玉琥. 仿制药有关物质研究的特点及研究思路. 中国执业药师, 2010, 6(8): 31-34.
Zhang Y H. The Characteristics and thoughts on the study of related substances in generic drugs. China Licensed Pharmacist, 2010, 6(8): 31-34. (in Chinese)
[12 ] PRASADA RAJU V V N K V, REDDY G M, RAVINDRA V, MATHAD V T, REDDY P. Synthesis and spectral characterization of related substances of lacidipine, an antihypertensive drug. Synthetic Communications, 2009, 39(12): 2137-2145
[13]   QIU F H, DANIEL L N. Identification of pharmaceutical impurities. Journal of Liquid Chromatography & Related Technologies, 2007, 30(5/7): 877-935.
[14]   YANG M, RICHARD T, YI H, GENE H. Characterization and control of impurities in the synthesis of an amino acid drug candidate. Journal of Liquid Chromatography & Related Technologies, 2007, 29(3): 365-375.
[15]   SMIRNOVA T A, GAVRILOV M Y, VOSEKOVA L P, NAZMETDINOV F Y, KOLLA V E. Synthesis and pharmacological activity of isopropylamides of 2-arylamino-5, 6, 7, 8-tetrahydroquinoline- 4- carboxylic acids. Pharmaceutical Chemistry Journal, 1997, 31(3): 134-136.
[16]   SMIRNOVA T A, GAVRILOV M Y, NAZMETDINOV F Y, KOLLA V E, KON`SHIN M E. Synthesis and antidepressant activity of acylhydrazides of 2-chloroand 2-anilino-5, 6, 7, 8-tetrahydroquinoline- 4-carboxylic acids. Pharmaceutical Chemistry Journal, 1999, 33(7): 370-371.
[17]   金翔飞, 沈卫阳, 党柱, 宫旭, 柯梦云, 王欢欢. 药物中有关物质的色谱分析研究近况. 药学进展, 2009, 33(12): 542-548.
JIN X F, SHEN W Y, DANG Z, GONG X, KE M Y, WANG H H. Recent process in studies on chromatographic method for analysis of the ralated impurities in drugs. Process in Pharmaceutical Sciences, 2009, 33(12): 542-548. (in Chinese)
[18]   RAJU T S, KALYANARAMAN L, REDDY V V, SWAMY Y P. Development and validation of an UPLC method for the rapid separation of positional isomers and potenial impurities of rivastigmine hydrogen tartrate in drug substance and drug product. Journal of Liquid Chromatography & Related Technologies, 2012, 35(7): 896-911.
[19]   KADIVAR M H, SINHA P K, PIJUSH J, HITESH S, ATUL B. Study of impurity carryover and impurity profile in febuxostat drug substance by LC-MS/MS technique. Journal of Pharmaceutical and Biomedical Analysis, 2011, 56(4): 749-757.
[20]   SATYANARAYANA K, SRINIVAS K, HIMABINDU V, REDDY G M. Impurity profile study of dutasteride. Pharmazie Die, 2007, 62(10): 743-746.
[21]   Ghassempour A, Rafati H, Adlnasab L, Bashour Y, Ebrahimzadeh H, Erfan M. Investigation of the solid state properties of amoxicillin trihydrate and the effect of powder PH. Aaps PharmSciTech, 2007, 8(4): 91-96.
[22]   CHEN Y W, LIU Y, NOVAK T, FREY L, CAMPOS K, KLAPARS A, CHEN C Y, PHENIX B. Identification and structural elucidation of process impurities generated in the end-game synthesis of taranabant (MK-0364)via cyanuric chloride. Journal of Pharmaceutical & Biomedical Analysis, 2009, 49(3): 702-710.
[23]   STOLARCZYK E U, KUTNER A. Use of hyphenated LC-MS/MS technique for characterization of impurity profile of quetiapine during drug development. Acta Poloniae Pharmaceutica, 2010, 67(6): 599- 608.
[24]   RAO R N, RAJU A N, NARSIMHA R. Isolation and characterization of process related impurities and degradation products of bicalutamide and development of RP-HPLC method for impurity profile study. Journal of Pharmaceutical and Biomedical Analysis, 2008, 46(3): 505-519.
[25]   FDA. Quality by design (QbD) for a modified release dosage form [EB/OL]. (2011-12) [2015-11]. http://www.fda.gov/downloads/Drugs/ DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/UCM286595. pdf
[26]   农业部兽药评审中心. 兽药质量标准汇编[S]. 北京: 中国农业出版社, 2012.

China Institute of Veterinary Drugs Control. Veterinary Drug Quality Standard Assembly[S]. Beijing: China Agriculture Press, 2012. (in Chinese)
[27]   谢沐风. 仿制药研发中有关物质研究思路之我见. 中国医药工程杂质, 2013, 44(11): 1174-1183.
Xie M F. Some opinions on the studies of related substances in generic drugs. Chinese Journal of Pharmaceuticals, 2013, 44(11): 1174-1183. (in Chinese)
[28]   邓晶晶, 张春然, 唐克慧, 徐明琴, 王宇驰, 邱建军. 反相高效液相色谱法测定头孢美唑钠中的有关物质. 中国新药杂志, 2011, 20(9): 828-832.
DENG J J, ZHANG C R, TANG K H, XU M Q, WANG Y C, QIU J J. Determination of the related substances in cefmetazole solium by RP-HPCL. Chinese Journal of New Drugs, 2011, 20(9): 828-832. (in Chinese)
[29]   樊后民, 王刚林. 高效液相色谱法测定头孢噻吩钠中的有关物质. 中国药房, 2005, 16(11): 860-861.
FAN H M, WANG G L. Determination of the related substances in Cefalotin by HPCL. China Pharmacy, 2005, 16(11): 860-861. (in Chinese)
[1] WU Tong, ZHANG Dao-kang, LIU Mao-lin, HUANG Hui-li, ZHANG Ning, XU Fei, LIU Yi-ming. The Safety Evaluation of Cefquinome Sulfate Intramammary Infusion (Dry Cow) [J]. Scientia Agricultura Sinica, 2016, 49(20): 4040-4046.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!